How should febuxostat be prescribed, and is it taken once daily?

Febuxostat Dosing and Administration

Febuxostat is a once-daily oral medication that should be started at 40 mg daily and titrated to 80 mg daily if needed to achieve target serum uric acid levels below 6 mg/dL. 1

Starting Dose and Titration Strategy

• Start febuxostat at 40 mg once daily (or ≤40 mg/day) rather than at higher doses to minimize the risk of triggering acute gout flares 1
• Measure serum uric acid every 2-5 weeks during dose titration to guide adjustments 1
• If serum uric acid remains ≥6 mg/dL after 2 weeks at 40 mg daily, increase to 80 mg once daily 2
• The 80 mg dose achieves target serum uric acid <6 mg/dL in 67% of patients, compared to only 42% with allopurinol 300 mg 1

Maximum Approved Dosing

• The maximum FDA-approved dose in the United States is 80 mg daily 1, 3
• Doses of 120 mg daily are approved in some countries outside the USA for refractory cases, though not FDA-approved 1
• Clinical trials studied 120 mg and 240 mg daily doses with greater uric acid reduction, but these remain off-label in the US 1

Mandatory Flare Prophylaxis

• Always provide anti-inflammatory prophylaxis when starting febuxostat: colchicine 0.5-1 mg daily, low-dose NSAIDs (if not contraindicated), or prednisone/prednisolone 1
• Continue prophylaxis for at least 3-6 months after initiating therapy 1
• This prophylaxis is strongly recommended by the American College of Rheumatology to prevent acute gout flares that commonly occur when starting urate-lowering therapy 1

Dosing in Renal Impairment

• No dose adjustment is required for febuxostat regardless of chronic kidney disease stage, including severe impairment (eGFR <30 mL/min) 1
• Start at 40 mg daily even in CKD patients 1
• For dialysis patients, consider starting at 20-40 mg daily as initial doses of 80 mg were associated with higher adverse events (odds ratio 8.25) 4
• Febuxostat remains effective in end-stage kidney disease, with mean serum uric acid reduced from 9.36 mg/dL to 3.71 mg/dL at 3 months 4

Administration Timing

• Febuxostat can be taken at any time of day; the American College of Rheumatology emphasizes consistent daily administration rather than specific timing 5
• The medication is taken once daily without regard to meals 2

Target Monitoring

• Target serum uric acid level is <6 mg/dL for all gout patients, maintained lifelong 1
• For severe gout with tophi, target <5 mg/dL until complete crystal dissolution, then relax to <6 mg/dL 1
• Continue monitoring every 6 months after achieving target to assess medication adherence 1

Critical Pitfall to Avoid

• Most patients require the full 80 mg dose to reach target—do not leave patients on 40 mg without checking serum uric acid levels, as this is inadequate for the majority 1
• Never combine febuxostat with allopurinol, as both are xanthine oxidase inhibitors with redundant mechanisms and the combination is explicitly prohibited 1

Cardiovascular Considerations

• Febuxostat carries an FDA black box warning regarding cardiovascular risk 1
• The American College of Rheumatology conditionally recommends switching to alternative urate-lowering therapy for patients with a history of cardiovascular disease or new cardiovascular events 1
• Use shared decision-making when prescribing to patients at high cardiovascular risk 1